Skip to content
DeepViews
排名

最高毛利率 — Healthcare

毛利率衡量扣除销售成本后保留的营收百分比。

共 52 家公司有毛利率数据。

按毛利率排名(52)
#代码名称市值毛利率
1LICN
Lichen International Limited
FY · 2025-12-31
$20M1129.4%
2CLLS
CELLECTIS S.A.
FY · 2025-12-31
$342M100.0%
3BRTX
BIORESTORATIVE THERAPIES, INC.
FY · 2025-12-31
$5M93.4%
4CGEN
Compugen Ltd
FY · 2025-12-31
$246M87.3%
5NNNN
Anbio Biotechnology
FY · 2025-12-31
$337M87.2%
6PLSM
Pulsenmore Ltd.
FY · 2025-12-31
$17M84.2%
7INMD
InMode Ltd.
FY · 2025-12-31
$855M78.5%
8BNR
Burning Rock Biotech Limited
FY · 2025-12-31
$107M74.7%
9BWAY
Brainsway Ltd.
FY · 2024-12-31
$575M74.6%
10EGG
ENIGMATIG LIMITED
FY · 2025-09-30
$80M68.8%
11SNYR
SYNERGY CHC CORP.
TTM · 2026-03-31
$2M65.4%
12CLGN
CollPlant Biotechnologies Ltd.
FY · 2025-12-31
$7M64.8%
13AYTU
AYTU BIOPHARMA, INC
TTM · 2026-03-31
$24M64.8%
14MDXH
MDXHEALTH SA
FY · 2025-12-31
$69M64.5%
15INTJ
Intelligent Group Limited
FY · 2025-11-30
$5M63.8%
16ITOC
iTonic Holdings Ltd
FY · 2025-12-31
$5M62.6%
17QGEN
QIAGEN N.V.
FY · 2025-12-31
$8.9B62.2%
18NVMI
NOVA LTD.
FY · 2025-12-31
$11.1B57.4%
19ALC
Alcon Inc.
FY · 2025-12-31
$34.8B55.2%
20CAMT
Camtek Ltd.
FY · 2025-12-31
$6.3B50.5%
21AVNS
AVANOS MEDICAL, INC.
TTM · 2026-03-31
$1.2B50.0%
22SPPL
SIMPPLE LTD.
FY · 2025-12-31
$20M49.6%
23PHG
KONINKLIJKE PHILIPS NV
FY · 2025-12-31
$26.1B45.2%
24ACCL
ACCO GROUP HOLDINGS LIMITED
FY · 2025-06-30
$41M44.1%
25EUDA
EUDA HEALTH HOLDINGS LIMITED
FY · 2025-12-31
$44M43.9%
26GLXG
Galaxy Payroll Group Limited
FY · 2025-06-30
$6M42.6%
27AUNA
Auna S.A.
FY · 2024-12-31
$384M39.3%
28VALN
Valneva SE
FY · 2025-12-31
$610M38.7%
29ICCM
ICECURE MEDICAL LTD.
FY · 2025-12-31
$8M36.3%
30TRIB
TRINITY BIOTECH PLC
FY · 2024-12-31
$8M34.8%
31ZJYL
Jin Medical International Ltd.
FY · 2025-09-30
$172M29.2%
32STVN
Stevanato Group S.p.A.
FY · 2025-12-31
$5.7B29.0%
33YDES
YD BIO LIMITED
FY · 2025-12-31
$340M28.1%
34PDEX
PRO-DEX, INC.
TTM · 2026-03-31
$200M27.8%
35SNDL
SNDL Inc.
FY · 2025-12-31
$337M27.3%
36RYOJ
RYOJBABA CO., LTD.
FY · 2025-12-31
$67M26.6%
37MITQ
MOVING iMAGE TECHNOLOGIES INC.
FY · 2025-06-30
$6M25.2%
38WOK
WORK Medical Technology Group LTD
FY · 2025-09-30
$6M23.8%
39POAS
PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd
FY · 2025-04-30
$3M22.1%
40INNV
InnovAge Holding Corp.
TTM · 2026-03-31
$1.5B21.8%
41BON
BON NATURAL LIFE LIMITED
FY · 2025-09-30
$9M20.8%
42NIVF
NewGenIvf Group Ltd
FY · 2025-12-31
$3M20.2%
43MDWD
MEDIWOUND LTD.
FY · 2025-12-31
$163M19.2%
44POCI
PRECISION OPTICS CORPORATION, INC.
FY · 2025-06-30
$48M17.8%
45IMCC
IM Cannabis Corp.
FY · 2025-12-31
$2M17.7%
46JLHL
Julong Holding Limited
FY · 2025-09-30
$135M16.1%
47SUPX
SUPERX AI TECHNOLOGY LIMITED
FY · 2025-06-30
$406M10.2%
48BMRA
BIOMERICA, INC.
FY · 2025-05-31
$7M9.4%
49CCM
Concord Medical Services Holdings Ltd
FY · 2025-12-31
$21M5.7%
50APM
Aptorum Group Limited
FY · 2023-12-31
$570,062.52.4%
51NNOX
NANO-X IMAGING LTD
FY · 2025-12-31
$65M-98.2%
52SCNI
SCINAI IMMUNOTHERAPEUTICS LTD.
FY · 2025-12-31
$2M-202.3%
如何把排名页用到估值流程里

先看公司页

先确认商业模式、利润率、资本结构和当前估值倍数,避免只看单一排名就下结论。

再验证 WACC

倍数看起来便宜,不代表折现率合理。先验证资本成本,再决定 DCF 假设。

最后进入 DCF

用同一家公司对应的 DCF 页面验证合理价值区间,避免排名、倍数和现金流假设互相脱节。

数据每日更新 · 来源: SEC EDGAR, Polygon.io